US SB4134 | 2019-2020 | 116th Congress

US Congress Senate Bill 4134 (Prior Session Legislation)

Status

Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on July 1 2020 - 25% progression, died in committee
Action: 2020-07-01 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requires the Centers for Medicare & Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the cost if the provider had furnished the underlying reference biological product instead.

Title

Increasing Access to Biosimilars Act of 2020

History

Date	Chamber	Action
2020-07-01	Senate	Read twice and referred to the Committee on Finance.

Same As/Similar To

HB6179 (Related) 2020-03-10 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.